Grants & Projects per year
Fingerprint
Dive into the research topics where David Hansen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 3, Open-Label, Multicenter, Single-Arm Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Dulaglutide 3.0 mg and 4.5 mg in Pediatric Participants 10 to Less than 18 Years of Age with Type 2 Diabetes Mellitus
Hansen, D. (PI)
Lilly USA Limited Liability Company
04/1/25 → 03/31/27
Project: Research
-
Type 1 Diabetes TrialNet
Weinstock, R. (PI), Izquierdo, R. (CoI), Sills, I. (CoI) & Hansen, D. (PI)
National Inst of Diabetes Digestive Kidney Disease
07/1/15 → 05/31/27
Project: Research
-
Erratum. Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial (Diabetes Care, 2025, 48, 1598–1606 (10.2337/dc25-0141))
Omnipod 5 Exercise Research Group, Jan 2026, In: Diabetes Care. 49, 1, p. 211 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Use of the Omnipod 5 Automated Insulin Delivery System Activity Feature Reduces Insulin Delivery and Attenuates the Drop in Glycemia Associated With Exercise in a Randomized Controlled Trial
Omnipod 5 Exercise Research Group, Sep 2025, In: Diabetes Care. 48, 9, p. 1598-1606 9 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery System
for the Omnipod 5 in Preschoolers Study Group, May 30 2024, In: Diabetes Technology and Therapeutics. 26, 6, p. 383-393 11 p.Research output: Contribution to journal › Article › peer-review
Open Access30 Scopus citations -
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetes
for the Omnipod 5 in Preschoolers Study Group, Dec 2024, In: Diabetes, Obesity and Metabolism. 26, 12, p. 5569-5579 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes
The Omnipod 5 Research Group, Jan 1 2024, In: Diabetes Technology and Therapeutics. 26, 1, p. 11-23 13 p.Research output: Contribution to journal › Article › peer-review
Open Access44 Scopus citations